Adicet Bio, Inc. (ACET)
USD 0.67
(-0.57%)
USD 0.67
(-0.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -138.78 Million USD | 41.35% |
| 2022 | -236.63 Million USD | 7.78% |
| 2021 | -256.6 Million USD | -309.31% |
| 2020 | -62.69 Million USD | -160.59% |
| 2019 | 103.47 Million USD | 2733.65% |
| 2018 | -3.92 Million USD | -101.31% |
| 2017 | 300.31 Million USD | 477.97% |
| 2016 | 51.96 Million USD | -31.75% |
| 2015 | 76.13 Million USD | 21.62% |
| 2014 | 62.6 Million USD | 5487.61% |
| 2013 | -1.16 Million USD | -105.56% |
| 2012 | 20.9 Million USD | -20.62% |
| 2011 | 26.33 Million USD | 861.41% |
| 2010 | 2.73 Million USD | 107.4% |
| 2009 | -37.02 Million USD | -39.35% |
| 2008 | -26.56 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -204.93 Million USD | 9.94% |
| 2024 Q1 | -227.55 Million USD | -63.96% |
| 2023 Q4 | -138.78 Million USD | 14.04% |
| 2023 FY | -138.78 Million USD | 41.35% |
| 2023 Q1 | -208.14 Million USD | 12.04% |
| 2023 Q3 | -161.46 Million USD | 11.68% |
| 2023 Q2 | -182.81 Million USD | 12.17% |
| 2022 Q4 | -236.63 Million USD | 9.32% |
| 2022 FY | -236.63 Million USD | 7.78% |
| 2022 Q3 | -260.96 Million USD | -9.53% |
| 2022 Q2 | -238.25 Million USD | 7.4% |
| 2022 Q1 | -257.29 Million USD | -0.27% |
| 2021 Q2 | -188.18 Million USD | 6.13% |
| 2021 Q4 | -256.6 Million USD | -49.45% |
| 2021 Q1 | -200.46 Million USD | -219.77% |
| 2021 Q3 | -171.69 Million USD | 8.76% |
| 2021 FY | -256.6 Million USD | -309.31% |
| 2020 Q4 | -62.69 Million USD | -1.44% |
| 2020 Q2 | -18.26 Million USD | -170.9% |
| 2020 Q3 | -61.8 Million USD | -238.37% |
| 2020 Q1 | -6.74 Million USD | 36.44% |
| 2020 FY | -62.69 Million USD | -160.59% |
| 2019 FY | 103.47 Million USD | 2733.65% |
| 2019 Q4 | -10.6 Million USD | 55.1% |
| 2019 Q3 | -23.62 Million USD | -10.53% |
| 2019 Q1 | 24.64 Million USD | 449.96% |
| 2019 Q2 | -21.37 Million USD | -186.72% |
| 2018 Q4 | -7.04 Million USD | 69.19% |
| 2018 Q2 | -51.35 Million USD | 62.16% |
| 2018 Q3 | -22.85 Million USD | 55.49% |
| 2018 Q1 | -135.7 Million USD | -154.37% |
| 2018 FY | -3.92 Million USD | -101.31% |
| 2017 Q4 | -53.34 Million USD | 0.0% |
| 2017 FY | 300.31 Million USD | 477.97% |
| 2017 Q2 | 297.98 Million USD | -3.2% |
| 2017 Q1 | 307.82 Million USD | -2.25% |
| 2016 Q3 | 47.03 Million USD | -9.49% |
| 2016 FY | 51.96 Million USD | -31.75% |
| 2016 Q1 | 64.33 Million USD | 4.21% |
| 2016 Q2 | 51.96 Million USD | -19.23% |
| 2016 Q4 | 314.92 Million USD | 569.63% |
| 2015 Q1 | 73.49 Million USD | 3.46% |
| 2015 Q3 | 79.27 Million USD | 4.13% |
| 2015 Q4 | 61.73 Million USD | -22.13% |
| 2015 FY | 76.13 Million USD | 21.62% |
| 2015 Q2 | 76.13 Million USD | 3.59% |
| 2014 Q2 | 62.6 Million USD | 622.61% |
| 2014 Q4 | 71.04 Million USD | 5.03% |
| 2014 Q3 | 67.63 Million USD | 8.04% |
| 2014 Q1 | -11.97 Million USD | 31.6% |
| 2014 FY | 62.6 Million USD | 5487.61% |
| 2013 FY | -1.16 Million USD | -105.56% |
| 2013 Q2 | -1.16 Million USD | -113.76% |
| 2013 Q3 | -8.8 Million USD | -657.75% |
| 2013 Q4 | -17.51 Million USD | -98.91% |
| 2013 Q1 | 8.44 Million USD | -62.17% |
| 2012 Q1 | 23.68 Million USD | 0.35% |
| 2012 FY | 20.9 Million USD | -20.62% |
| 2012 Q2 | 20.9 Million USD | -11.76% |
| 2012 Q3 | 23.87 Million USD | 14.21% |
| 2012 Q4 | 22.32 Million USD | -6.49% |
| 2011 Q4 | 23.6 Million USD | 11.29% |
| 2011 FY | 26.33 Million USD | 861.41% |
| 2011 Q3 | 21.21 Million USD | -19.45% |
| 2011 Q2 | 26.33 Million USD | -7.66% |
| 2011 Q1 | 28.51 Million USD | 50.97% |
| 2010 Q3 | -11.8 Million USD | -531.07% |
| 2010 Q4 | 18.88 Million USD | 259.97% |
| 2010 Q1 | -8.58 Million USD | 64.08% |
| 2010 FY | 2.73 Million USD | 107.4% |
| 2010 Q2 | 2.73 Million USD | 131.9% |
| 2009 Q2 | -37.02 Million USD | -65.29% |
| 2009 Q4 | -23.9 Million USD | 24.96% |
| 2009 Q1 | -22.39 Million USD | 12.18% |
| 2009 Q3 | -31.86 Million USD | 13.94% |
| 2009 FY | -37.02 Million USD | -39.35% |
| 2008 Q2 | -26.56 Million USD | -74.83% |
| 2008 Q4 | -25.5 Million USD | -81.46% |
| 2008 FY | -26.56 Million USD | 0.0% |
| 2008 Q1 | -15.19 Million USD | 24.6% |
| 2008 Q3 | -14.05 Million USD | 47.1% |
| 2007 Q4 | -20.15 Million USD | 1.62% |
| 2007 Q3 | -20.48 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -148.1% |
| Alkermes plc | -166.73 Million USD | 16.764% |
| Agenus Inc. | 274.13 Million USD | 150.627% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.422% |
| Aptorum Group Limited | 1.35 Million USD | 10327.14% |
| Ardelyx, Inc. | 34.51 Million USD | 502.141% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3342.687% |
| Bicycle Therapeutics plc | -481.46 Million USD | 71.174% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 483.782% |
| ChromaDex Corporation | -24.04 Million USD | -477.125% |
| Chimerix, Inc. | -25.51 Million USD | -443.9% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2091.755% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -486.168% |
| CRISPR Therapeutics AG | -150.84 Million USD | 7.994% |
| Precision BioSciences, Inc. | -85.41 Million USD | -62.495% |
| Dyadic International, Inc. | -6.37 Million USD | -2075.993% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -771.066% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1910.659% |
| Lantern Pharma Inc. | -21.7 Million USD | -539.475% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -25.557% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1524.536% |
| Incyte Corporation | -3.17 Billion USD | 95.629% |
| IO Biotech, Inc. | -140.69 Million USD | 1.359% |
| Jaguar Health, Inc. | 29.39 Million USD | 572.209% |
| Novavax, Inc. | -298.29 Million USD | 53.473% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2700.468% |
| Opthea Limited | 28.15 Million USD | 592.896% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -726.654% |
| ContextLogic Inc. | -232 Million USD | 40.178% |
| MiMedx Group, Inc. | -33.9 Million USD | -309.389% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1461.324% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5889.874% |
| NextCure, Inc. | -6.47 Million USD | -2042.767% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -174.82% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2075.686% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1241.034% |
| Vaxcyte, Inc. | -368.22 Million USD | 62.309% |
| PDS Biotechnology Corporation | -32.7 Million USD | -324.31% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 903.258% |
| Pharming Group N.V. | 109.8 Million USD | 226.395% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -697.81% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 20.797% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -649.396% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -649.396% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1854.746% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2268.379% |
| Acelyrin, Inc. | -216.9 Million USD | 36.014% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2373.804% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7950.29% |
| Summit Therapeutics Inc. | 34.67 Million USD | 500.262% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1940.085% |
| Senti Biosciences, Inc. | 1.74 Million USD | 8076.264% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 24.82% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -79.193% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2189.459% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 139208.34% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 22199.841% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -18.575% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 17.503% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 225.18% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1727.106% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -7.492% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2112.982% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 42.736% |
| Immix Biopharma, Inc. | -17.5 Million USD | -692.625% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 56.178% |
| MEI Pharma, Inc. | -3.7 Million USD | -3645.938% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1209.32% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 185.808% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 599.36% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1910.659% |
| Precigen, Inc. | -481 Thousand USD | -28753.846% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1085.633% |
| AlloVir, Inc. | -62.69 Million USD | -121.379% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -149.554% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 325.062% |
| ImmuCell Corporation | 10.99 Million USD | 1362.783% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 9.964% |
| Onconetix, Inc. | 5.33 Million USD | 2703.182% |
| PureTech Health plc | -167.19 Million USD | 16.992% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -355.637% |
| Elevation Oncology, Inc. | -19.11 Million USD | -625.949% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2727.195% |
| Seer, Inc. | -4.24 Million USD | -3173.278% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -477.389% |
| Innoviva, Inc. | 255.56 Million USD | 154.306% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -148.437% |
| ESSA Pharma Inc. | -33.62 Million USD | -312.791% |
| GlycoMimetics, Inc. | -40.98 Million USD | -238.633% |
| GT Biopharma, Inc. | -1.02 Million USD | -13493.242% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -104.752% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 326.565% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -3.511% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -901.638% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -380.698% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -184128.901% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -349.702% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1593.587% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4335.481% |
| Soligenix, Inc. | -4.95 Million USD | -2702.873% |
| Century Therapeutics, Inc. | 847 Thousand USD | 16485.714% |
| Kura Oncology, Inc. | -20.11 Million USD | -589.865% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -239.117% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1552.62% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7718.564% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4241.164% |
| Autolus Therapeutics plc | -186.59 Million USD | 25.623% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -181.492% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 49.677% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 505.005% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 184.437% |
| GRI Bio, Inc. | -1.79 Million USD | -7636.176% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1444.988% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -317.317% |
| IGM Biosciences, Inc. | -72.6 Million USD | -91.151% |
| INmune Bio, Inc. | -25.41 Million USD | -446.169% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 191.942% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -173.963% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -754.107% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4710.765% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 465.085% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -236.984% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 535.274% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 136.721% |
| Verastem, Inc. | -37.27 Million USD | -272.303% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1429.67% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -167.608% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -816.994% |
| Histogen Inc. | -7.48 Million USD | -1753.706% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -542.33% |
| Surrozen, Inc. | -32.66 Million USD | -324.893% |
| Organovo Holdings, Inc. | -1.5 Million USD | -9109.489% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3201.71% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 831.991% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5405.313% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3439.437% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1555.942% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -219.477% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -852.105% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 56.189% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -19120.979% |
| Apollomics, Inc. | -27.39 Million USD | -406.614% |
| Amarin Corporation plc | -191.04 Million USD | 27.352% |
| Mesoblast Limited | 55.96 Million USD | 347.998% |
| Turnstone Biologics Corp. | -14.58 Million USD | -851.639% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -448.739% |
| Synaptogenix, Inc. | -28.66 Million USD | -384.228% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -14727.671% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 384.796% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15998.918% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1810.067% |
| Exelixis, Inc. | -73.05 Million USD | -89.989% |
| Better Therapeutics, Inc. | -860 Thousand USD | -16038.023% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -477.966% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 42.501% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18955.239% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1765.884% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 11167.544% |
| Gritstone bio, Inc. | 39.49 Million USD | 451.448% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -65.024% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -5172.782% |
| Avid Bioservices, Inc. | 169.72 Million USD | 181.77% |
| Insmed Incorporated | 721.62 Million USD | 119.233% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1418.206% |
| MediWound Ltd. | -5.32 Million USD | -2507.798% |
| OmniAb, Inc. | 9.2 Million USD | 1608.063% |
| Alector, Inc. | -35.63 Million USD | -289.446% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 261.435% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2716.295% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1148.319% |
| Zai Lab Limited | -775 Million USD | 82.092% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 140.753% |
| Aura Biosciences, Inc. | -21.52 Million USD | -544.771% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -68.267% |
| Immunic, Inc. | -45.34 Million USD | -206.103% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 28.17% |
| Veracyte, Inc. | -203.82 Million USD | 31.908% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 121.743% |
| FibroGen, Inc. | 56.76 Million USD | 344.485% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1658.529% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4809.196% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6603.559% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.023% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4054.056% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 16.375% |
| TG Therapeutics, Inc. | 17.86 Million USD | 876.996% |
| Galecto, Inc. | -21.21 Million USD | -554.162% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -483.506% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.843% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -467.126% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1106.109% |
| XBiotech Inc. | -200.02 Million USD | 30.614% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -65.024% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3165.084% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -293.577% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -79.734% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2538.71% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 18.559% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -50.245% |
| Vaxxinity, Inc. | 10.13 Million USD | 1469.789% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 118.85% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1188.937% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -110.424% |
| NexImmune, Inc. | -3.13 Million USD | -4328.935% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3919.697% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -818.423% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -412.129% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1446.192% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -111308.389% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -242.076% |
| Ainos, Inc. | 4.07 Million USD | 3503.371% |
| Pluri Inc. | 22.82 Million USD | 707.942% |
| Prothena Corporation plc | -608.34 Million USD | 77.186% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -16.867% |
| Celularity Inc. | 65.19 Million USD | 312.896% |
| Rallybio Corporation | -24.1 Million USD | -475.832% |
| Cue Biopharma, Inc. | -33.81 Million USD | -310.382% |
| MeiraGTx Holdings plc | -40.3 Million USD | -244.368% |
| Omeros Corporation | 331.17 Million USD | 141.907% |
| Humacyte, Inc. | -22.48 Million USD | -517.215% |
| Immunocore Holdings plc | -358.59 Million USD | 61.297% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -464.749% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -349.134% |
| Blueprint Medicines Corporation | 702.83 Million USD | 119.747% |
| CalciMedica, Inc. | -5.53 Million USD | -2409.711% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 26.263% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1258.792% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -246.647% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -317.367% |
| Pulmatrix, Inc. | -10.41 Million USD | -1232.313% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2222.018% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -263.869% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -24.582% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -131.528% |
| Cytokinetics, Incorporated | 642.37 Million USD | 121.605% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2283.428% |
| Nutriband Inc. | -251.65 Thousand USD | -55049.271% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -306.773% |
| Vor Biopharma Inc. | 4.3 Million USD | 3327.605% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.701% |
| Evogene Ltd. | -19.63 Million USD | -606.871% |
| ProKidney Corp. | -56.23 Million USD | -146.794% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -185.148% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1402.481% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 110.176% |
| CorMedix Inc. | -43.05 Million USD | -222.367% |
| BioLineRx Ltd. | 7.33 Million USD | 1991.862% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -405.323% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 400.75% |
| Atai Life Sciences N.V. | -28.55 Million USD | -385.983% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6322.156% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -508.288% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 882.56% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -84.867% |
| MediciNova, Inc. | -50.78 Million USD | -173.291% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -76.114% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -616868.215% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2050.873% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 30.544% |
| Biomea Fusion, Inc. | -166.57 Million USD | 16.679% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 22.455% |
| Mereo BioPharma Group plc | -51.46 Million USD | -169.652% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -46.332% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 52.755% |
| Absci Corporation | -72.59 Million USD | -91.172% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3139.575% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 40.8% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -47.315% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -45.029% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -255.199% |
| Allakos Inc. | -24.97 Million USD | -455.704% |
| Imunon, Inc. | -4.21 Million USD | -3193.59% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -841.439% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -2.501% |
| BioAtla, Inc. | -109.01 Million USD | -27.315% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18955.239% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -14680.298% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1259.845% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -554.563% |
| XOMA Corporation | -29 Million USD | -378.576% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -738.086% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1439.341% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1763.163% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -11.354% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 33.328% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -69.71% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -49.615% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -16053.35% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3509.545% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8651.843% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 110.051% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11581.08% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3260.715% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 222.3% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 192961.51% |
| Orgenesis Inc. | 21.78 Million USD | 737.105% |
| Entera Bio Ltd. | -10.62 Million USD | -1205.739% |
| GH Research PLC | -78.07 Million USD | -77.757% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -522.698% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -420.601% |
| Xencor, Inc. | 29.64 Million USD | 568.179% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6945.698% |
| Replimune Group, Inc. | 1.41 Million USD | 9929.108% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -56569.035% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -9.785% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11581.08% |
| Portage Biotech Inc. | -4.98 Million USD | -2686.328% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -616868.215% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -109.895% |
| OncoCyte Corporation | -6.56 Million USD | -2014.688% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 15565.232% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2946.485% |
| Purple Biotech Ltd. | -14.13 Million USD | -881.659% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -484.219% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2020.504% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -731.45% |
| HilleVax, Inc. | -165.48 Million USD | 16.133% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5368.361% |
| Tharimmune, Inc. | -10.93 Million USD | -1169.159% |
| Genprex, Inc. | -6.73 Million USD | -1959.879% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 62.369% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -56.892% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9806.281% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4084.18% |
| OKYO Pharma Limited | -826.84 Thousand USD | -16685.068% |
| Savara Inc. | 153 Thousand USD | 90810.458% |
| Curis, Inc. | -23.88 Million USD | -481.015% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2590.76% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -17784.646% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2135.615% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11811.983% |
| BeiGene, Ltd. | -2.25 Billion USD | 93.84% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1224.829% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 77.181% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 25.217% |
| Erasca, Inc. | -37.21 Million USD | -272.923% |
| bluebird bio, Inc. | 108.57 Million USD | 227.831% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10676.283% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 136.644% |
| DBV Technologies S.A. | -126.98 Million USD | -9.293% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10676.283% |
| Moderna, Inc. | -2.9 Billion USD | 95.226% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1240.678% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1177.024% |
| Molecular Templates, Inc. | 707 Thousand USD | 19730.41% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -342.405% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 140.041% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -69.125% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -51.299% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -330.054% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -303.732% |
| MacroGenics, Inc. | -66.98 Million USD | -107.191% |
| RenovoRx, Inc. | -1.17 Million USD | -11731.799% |
| Prime Medicine, Inc. | -27.94 Million USD | -396.715% |
| Aditxt, Inc. | 18.12 Million USD | 865.895% |
| Adagene Inc. | -87.62 Million USD | -58.383% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3231.879% |
| Quantum-Si incorporated | -118.55 Million USD | -17.064% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 485.466% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1756.884% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -186.106% |
| SciSparc Ltd. | -2.06 Million USD | -6620.92% |
| Vericel Corporation | 1.27 Million USD | 10968.207% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1057.359% |
| Minerva Neurosciences, Inc. | 41 Million USD | 438.47% |
| Generation Bio Co. | 31.44 Million USD | 541.322% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 20.858% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -348.815% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 219.035% |
| Invivyd, Inc. | -198.47 Million USD | 30.074% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -53.747% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5688.367% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -96.055% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1933.509% |
| 2seventy bio, Inc. | 181.71 Million USD | 176.376% |
| ADMA Biologics, Inc. | 90.06 Million USD | 254.095% |
| Clene Inc. | 3.34 Million USD | 4255.299% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1428.036% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -545.191% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2050.873% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 59.669% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -433.803% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 178.117% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3292.026% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2874.63% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2564.369% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -6.51% |
| Evaxion Biotech A/S | 5.28 Million USD | 2725.139% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -23.292% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -5.724% |
| Trevena, Inc. | 2.25 Million USD | 6246.457% |
| Surrozen, Inc. | -32.66 Million USD | -324.893% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -169.437% |
| Cingulate Inc. | 3.08 Million USD | 4602.15% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4625.468% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2031.084% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1393.742% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -74.964% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -5.58% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -31.499% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3420.157% |
| Kronos Bio, Inc. | -36.05 Million USD | -284.942% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1575.045% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9618.17% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -155.8% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1062.702% |
| ImmunityBio, Inc. | 618.22 Million USD | 122.449% |
| Korro Bio, Inc. | -132.94 Million USD | -4.396% |
| Kineta, Inc. | -4.54 Million USD | -2956.309% |
| BioVie Inc. | -17.73 Million USD | -682.677% |
| Codexis, Inc. | -43.27 Million USD | -220.739% |
| Celularity Inc. | 65.19 Million USD | 312.896% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4279.52% |
| Celcuity Inc. | 6.78 Million USD | 2145.947% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4024.497% |
| Cibus, Inc. | -8.07 Million USD | -1618.086% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3181.792% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3136.915% |
| IN8bio, Inc. | -16.38 Million USD | -746.83% |
| Kodiak Sciences Inc. | -103.87 Million USD | -33.61% |
| Annexon, Inc. | -193.75 Million USD | 28.37% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 385619.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -693.114% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3850.669% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 113.164% |
| Eyenovia, Inc. | 1.25 Million USD | 11126.2% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 615.841% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4179.587% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -317.442% |
| Arcellx, Inc. | -296.95 Million USD | 53.264% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -611.509% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -135.732% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -569.595% |
| Moolec Science SA | 117.61 Thousand USD | 118100.102% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -261.434% |
| Geron Corporation | 14.76 Million USD | 1040.228% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -266.019% |
| Royalty Pharma plc | 5.65 Billion USD | 102.453% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 1.863% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1885.671% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2487.929% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 1.381% |
| Humacyte, Inc. | -22.48 Million USD | -517.215% |
| Structure Therapeutics Inc. | -124.33 Million USD | -11.62% |
| 89bio, Inc. | -289.05 Million USD | 51.986% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -449.826% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7683.904% |
| Genelux Corporation | -6.89 Million USD | -1911.697% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -346.85% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 266.015% |
| Notable Labs, Ltd. | -9.77 Million USD | -1319.671% |
| Liquidia Corporation | -80.17 Million USD | -73.103% |
| Mustang Bio, Inc. | -3.73 Million USD | -3614.855% |
| Immunovant, Inc. | -635.22 Million USD | 78.152% |
| Quantum-Si incorporated | -118.55 Million USD | -17.064% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -690.179% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3249.916% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1829.002% |
| Acasti Pharma Inc. | -23 Million USD | -503.291% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4021.698% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -754.107% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -0.76% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4353.494% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -524.267% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -647.412% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 18.012% |
| PepGen Inc. | -60.67 Million USD | -128.757% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -504.052% |
| United Therapeutics Corporation | -507.7 Million USD | 72.664% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -625.646% |
| Solid Biosciences Inc. | -47.75 Million USD | -190.653% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15998.918% |
| Immuneering Corporation | -54.94 Million USD | -152.602% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3201.71% |
| Silo Pharma, Inc. | -3.52 Million USD | -3837.993% |
| Belite Bio, Inc | -87.27 Million USD | -59.03% |
| XOMA Corporation | -29 Million USD | -378.576% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -96.312% |
| Bionomics Limited | 227 Million USD | 161.137% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -19.354% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5379.155% |
| uniQure N.V. | -102.95 Million USD | -34.809% |
| Cassava Sciences, Inc. | -121.13 Million USD | -14.571% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3231.879% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 438.91% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1060.329% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4385.392% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 131031.132% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4179.587% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1658.529% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1771.454% |
| Altimmune, Inc. | -134.48 Million USD | -3.197% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 170.071% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5379.155% |
| Compugen Ltd. | -12.9 Million USD | -975.535% |
| Peak Bio, Inc. | 10.34 Million USD | 1442.214% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -48941.343% |
| Benitec Biopharma Inc. | -50.58 Million USD | -174.38% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -33.017% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 806.475% |
| Zura Bio Limited | -99.8 Million USD | -39.057% |
| PolyPid Ltd. | 6.17 Million USD | 2349.384% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 287.246% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 806.475% |
| Instil Bio, Inc. | 75.35 Million USD | 284.17% |
| argenx SE | -2.02 Billion USD | 93.159% |
| Immunome, Inc. | -97.02 Million USD | -43.037% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -516.968% |
| Verona Pharma plc | -220.44 Million USD | 37.042% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -93.45% |
| Shattuck Labs, Inc. | -121.42 Million USD | -14.299% |
| CervoMed Inc. | -7.79 Million USD | -1680.954% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 25.182% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3073.725% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -5.349% |
| Moolec Science SA | 117.61 Thousand USD | 118100.102% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5965.926% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 972.963% |
| AnaptysBio, Inc. | -18.15 Million USD | -664.625% |
| Design Therapeutics, Inc. | -18.15 Million USD | -664.667% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -97.194% |
| NeurAxis, Inc. | 145.7 Thousand USD | 95355.319% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1335.639% |
| Lumos Pharma, Inc. | -28.49 Million USD | -387.092% |
| Achilles Therapeutics plc | -126.92 Million USD | -9.347% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -93.45% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -21065.266% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -568.086% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9618.17% |
| Nutriband Inc. | -251.65 Thousand USD | -55049.271% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -953.732% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1765.417% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 140.796% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 684.736% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 68.984% |
| Palisade Bio, Inc. | -12.06 Million USD | -1050.518% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 1.086% |
| Beam Therapeutics Inc. | -262.72 Million USD | 47.173% |
| Neurogene Inc. | -131.95 Million USD | -5.178% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 736.171% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2743.996% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 63.205% |
| Sesen Bio, Inc. | -112.55 Million USD | -23.308% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -38.982% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5811.381% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -255.627% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -66.647% |
| Athira Pharma, Inc. | -88.99 Million USD | -55.942% |
| Vaccinex, Inc. | -1.28 Million USD | -10675.388% |
| HCW Biologics Inc. | 2.85 Million USD | 4958.339% |
| XOMA Corporation | -29 Million USD | -378.576% |
| Nektar Therapeutics | 210.24 Million USD | 166.014% |
| Arvinas, Inc. | -313.8 Million USD | 55.772% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8651.843% |
| Merus N.V. | -192.88 Million USD | 28.046% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 331.37% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1900.389% |
| Rezolute, Inc. | -68.16 Million USD | -103.596% |
| Clene Inc. | 3.34 Million USD | 4255.299% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -952.453% |
| BeyondSpring Inc. | -13.75 Million USD | -908.993% |
| Synlogic, Inc. | -6.68 Million USD | -1976.096% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 12338.713% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1541.478% |
| Peak Bio, Inc. | 10.34 Million USD | 1442.214% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -68.39% |
| Krystal Biotech, Inc. | -350.23 Million USD | 60.373% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 211.812% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 17.876% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4295.967% |
| MannKind Corporation | 143.89 Million USD | 196.448% |
| Ikena Oncology, Inc. | -109.15 Million USD | -27.146% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1733.14% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -319.296% |
| Gossamer Bio, Inc. | 180.35 Million USD | 176.952% |
| CohBar, Inc. | -5.93 Million USD | -2240.133% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -366.542% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3139.575% |
| Legend Biotech Corporation | -949.39 Million USD | 85.382% |
| Mural Oncology plc | -255.84 Million USD | 45.753% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 530.815% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2846.244% |
| Disc Medicine, Inc. | -358.28 Million USD | 61.263% |
| Champions Oncology, Inc. | 4.81 Million USD | 2984.185% |
| REGENXBIO Inc. | 54.76 Million USD | 353.409% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -51511.524% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 8.103% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1440.023% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -72.015% |
| Vaxart, Inc. | -8.24 Million USD | -1584.104% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -176.578% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -9.139% |
| Cellectis S.A. | -43.85 Million USD | -216.468% |
| Longeveron Inc. | -2.9 Million USD | -4672.593% |
| Repare Therapeutics Inc. | -107.85 Million USD | -28.676% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 114.332% |
| Inozyme Pharma, Inc. | 12 Million USD | 1256.173% |
| Revolution Medicines, Inc. | -608.2 Million USD | 77.181% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -11183.496% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 47.651% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 7.52% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -786.988% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -18655.0% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.549% |
| Denali Therapeutics Inc. | -74.86 Million USD | -85.383% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1057.359% |
| Veru Inc. | 4.77 Million USD | 3003.513% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1134.101% |
| Cingulate Inc. | 3.08 Million USD | 4602.15% |
| Passage Bio, Inc. | 4.58 Million USD | 3126.979% |
| Context Therapeutics Inc. | -14.44 Million USD | -860.475% |
| Exicure, Inc. | 5.84 Million USD | 2472.833% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 39.756% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -250.738% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 984.501% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -135.948% |
| Nuvalent, Inc. | -335.38 Million USD | 58.619% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 8102.29% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -86.336% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1461.159% |
| OmniAb, Inc. | 9.2 Million USD | 1608.063% |
| Anew Medical, Inc. | 1.43 Million USD | 9788.683% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 947.205% |
| Lipocine Inc. | -4.75 Million USD | -2819.01% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -26.368% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1011.214% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -173.963% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 657.557% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1964.975% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -110.836% |
| Ocugen, Inc. | -32.52 Million USD | -326.761% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -62.182% |
| Q32 Bio Inc. | -37.94 Million USD | -265.729% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -21999.841% |
| Alumis Inc. Common Stock | -13.52 Million USD | -925.848% |
| Equillium, Inc. | -22.39 Million USD | -519.806% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -442.815% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -325.378% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -55881.687% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 203.54% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4439.806% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 42356.296% |
| Dominari Holdings Inc. | 195 Thousand USD | 71272.821% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2535.074% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1456.432% |
| Bio-Techne Corporation | 267.74 Million USD | 151.835% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -756.234% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -17.522% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1551.636% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -997.044% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 43.38% |
| Nkarta, Inc. | 57.29 Million USD | 342.215% |
| BioCardia, Inc. | 212 Thousand USD | 65565.566% |
| Iterum Therapeutics plc | 13.43 Million USD | 1132.795% |